Viridian Therapeutics, Inc. (VRDN)
17.25
-0.28
(-1.60%)
USD |
NASDAQ |
May 07, 14:42
Viridian Therapeutics Cash from Investing (Quarterly) : 77.26M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Boston Scientific Corp. | -591.00M |
| Marker Therapeutics, Inc. | 0.00 |
| Plus Therapeutics, Inc. | -1.077M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -119.65M |
| Cash from Financing (Quarterly) | 6.357M |
| Free Cash Flow | -304.30M |
| Free Cash Flow Per Share (Quarterly) | -1.171 |
| Free Cash Flow to Equity (Quarterly) | -120.16M |
| Free Cash Flow to Firm (Quarterly) | -116.22M |
| Free Cash Flow Yield | -19.60% |